Literature DB >> 24459232

Adenine phosphoribosyltransferase deficiency as a rare cause of renal allograft dysfunction.

Kati Kaartinen1, Ulla Hemmilä, Kaija Salmela, Anne Räisänen-Sokolowski, Timo Kouri, Satu Mäkelä.   

Abstract

Adenine phosphoribosyltransferase deficiency is a rare autosomal recessive disorder manifesting as urolithiasis or crystalline nephropathy. It leads to the generation of large amounts of poorly soluble 2,8-dihydroxyadenine excreted in urine, yielding kidney injury and in some patients, kidney failure. Early recognition of the disease, institution of xanthine analog therapy to block the formation of 2,8-dihydroxyadenine, high fluid intake, and low purine diet prevent CKD. Because of symptom variability and lack of awareness, however, the diagnosis is sometimes extremely deferred. We describe a patient with adenine phosphoribosyltransferase deficiency who was diagnosed during evaluation of a poorly functioning second kidney allograft. This report highlights the risk of renal allograft loss in patients with undiagnosed adenine phosphoribosyltransferase deficiency and the need for improved early detection of this disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24459232      PMCID: PMC3968508          DOI: 10.1681/ASN.2013090960

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  11 in total

1.  Kidney transplantation in a patient with severe adenine phosphoribosyl transferase deficiency: obstacles and pitfalls.

Authors:  Anna Bertram; Verena Broecker; Frank Lehner; Anke Schwarz
Journal:  Transpl Int       Date:  2010-06-16       Impact factor: 3.782

2.  Adenine phosphoribosyltransferase deficiency and renal allograft dysfunction.

Authors:  B Benedetto; R Madden; A Kurbanov; G Braden; J Freeman; G S Lipkowitz
Journal:  Am J Kidney Dis       Date:  2001-05       Impact factor: 8.860

3.  Adenine phosphoribosyltransferase deficiency in children.

Authors:  Jérôme Harambat; Guillaume Bollée; Michel Daudon; Irène Ceballos-Picot; Albert Bensman
Journal:  Pediatr Nephrol       Date:  2012-01-03       Impact factor: 3.714

Review 4.  Adenine phosphoribosyltransferase deficiency.

Authors:  Guillaume Bollée; Jérôme Harambat; Albert Bensman; Bertrand Knebelmann; Michel Daudon; Irène Ceballos-Picot
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-14       Impact factor: 8.237

5.  Missense mutation in the adenine phosphoribosyltransferase gene causing 2,8-dihydroxyadenine urolithiasis.

Authors:  A Sahota; J Chen; S A Boyadjiev; M H Gault; J A Tischfield
Journal:  Hum Mol Genet       Date:  1994-05       Impact factor: 6.150

6.  2,8-Dihydroxyadenine lithiasis in a Japanese patient heterozygous at the adenine phosphoribosyltransferase locus.

Authors:  A Sahota; J Chen; M A Behzadian; R Ravindra; H Takeuchi; P J Stambrook; J A Tischfield
Journal:  Am J Hum Genet       Date:  1991-05       Impact factor: 11.025

7.  Clinical features and genotype of adenine phosphoribosyltransferase deficiency in iceland.

Authors:  V Edvardsson; R Palsson; I Olafsson; G Hjaltadottir; T Laxdal
Journal:  Am J Kidney Dis       Date:  2001-09       Impact factor: 8.860

8.  Decreased kidney function and crystal deposition in the tubules after kidney transplant.

Authors:  Piero Stratta; Giovanni Battista Fogazzi; Caterina Canavese; Andrea Airoldi; Roberta Fenoglio; Cristina Bozzola; Irène Ceballos-Picot; Guillaume Bollée; Michel Daudon
Journal:  Am J Kidney Dis       Date:  2010-03-19       Impact factor: 8.860

Review 9.  Hereditary causes of kidney stones and chronic kidney disease.

Authors:  Vidar O Edvardsson; David S Goldfarb; John C Lieske; Lada Beara-Lasic; Franca Anglani; Dawn S Milliner; Runolfur Palsson
Journal:  Pediatr Nephrol       Date:  2013-01-20       Impact factor: 3.714

10.  Crystalline nephropathy due to 2,8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure.

Authors:  Samih H Nasr; Sanjeev Sethi; Lynn D Cornell; Dawn S Milliner; Mark Boelkins; John Broviac; Mary E Fidler
Journal:  Nephrol Dial Transplant       Date:  2010-01-11       Impact factor: 5.992

View more
  7 in total

1.  A rare case of primary non-function of renal allograft due to adenine phosphoribosyltransferase deficiency.

Authors:  Benoit Brilland; Jean-François Augusto; Anne Croue; Jean-François Subra; Johnny Sayegh
Journal:  Int Urol Nephrol       Date:  2015-08-09       Impact factor: 2.370

Review 2.  Primary disease recurrence—effects on paediatric renal transplantation outcomes.

Authors:  Justine Bacchetta; Pierre Cochat
Journal:  Nat Rev Nephrol       Date:  2015-04-28       Impact factor: 28.314

3.  Recurrent 2,8-dihydroxyadenine nephropathy: a rare but preventable cause of renal allograft failure.

Authors:  M Zaidan; R Palsson; E Merieau; E Cornec-Le Gall; A Garstka; U Maggiore; P Deteix; M Battista; E-R Gagné; I Ceballos-Picot; J-P Duong Van Huyen; C Legendre; M Daudon; V O Edvardsson; B Knebelmann
Journal:  Am J Transplant       Date:  2014-10-10       Impact factor: 8.086

4.  Adenine phosphoribosyl transferase deficiency leads to renal allograft dysfunction in kidney transplant recipients: a systematic review.

Authors:  Ishfaq Rashid; Ashish Verma; Pramil Tiwari; Sanjay D'Cruz
Journal:  J Bras Nefrol       Date:  2022 Jul-Sep

5.  Kidney Transplant Outcomes in Patients With Adenine Phosphoribosyltransferase Deficiency.

Authors:  Hrafnhildur Linnet Runolfsdottir; Runolfur Palsson; Inger M Sch Agustsdottir; Olafur S Indridason; Jennifer Li; Myriam Dao; Bertrand Knebelmann; Dawn S Milliner; Vidar O Edvardsson
Journal:  Transplantation       Date:  2020-10       Impact factor: 5.385

Review 6.  Recurrence of crystalline nephropathy after kidney transplantation in APRT deficiency and primary hyperoxaluria.

Authors:  Guillaume Bollée; Pierre Cochat; Michel Daudon
Journal:  Can J Kidney Health Dis       Date:  2015-09-15

7.  Rare crystalline nephropathy leading to acute graft dysfunction: a case report.

Authors:  Sahil Bagai; Dinesh Khullar; Bhavna Bansal
Journal:  BMC Nephrol       Date:  2019-11-21       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.